Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
Clinical trial NCT07108140 · TERMINATED
Trial details
- NCT number
- NCT07108140
- Sponsor
- TCRCure Biopharma Ltd.
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-20
- Primary completion
- 2025-12-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.